Lactobacillus reuteri ATCC PTA 6475 (L. reuteri 6475)

DIETARY_SUPPLEMENT2 trials

Sponsors

Sahlgrenska University Hospital

Conditions

Bone LossPostmenopausal Osteoporosis

Unknown Phase

Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri

CompletedNCT04169789

Sahlgrenska University HospitalPostmenopausal Osteoporosis

Start: 2019-12-04End: 2022-10-18Updated: 2023-02-06

Prevention of Glucocorticoid Induced Impairment of Bone Metabolism

CompletedNCT04767711

Sahlgrenska University HospitalBone Loss

Start: 2022-05-16End: 2022-12-15Updated: 2023-02-06

Related Papers

Prevention of glucocorticoid-induced impairment of bone metabolism—a randomized, placebo-controlled, single centre proof-of-concept clinical trial

JBMR Plus2025-02-171 citations

<i>Limosilactobacillus reuteri</i> 6475 and Prevention of Early Postmenopausal Bone Loss

JAMA Network Open2024-06-1212 citations